Novo Nordisk A/S (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

NVO 45.73 +0.26 (0.57%)
price chart
Momentum Stocks in Focus - Novo Nordisk A/S (ADR)(NYSE:NVO), XOMA Corp ...
Las Vegas, NV - 19 July, 2014 - (TechSonian) �EquityObserver.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
Watch List: Lannett Company (NYSE:LCI), Novo Nordisk A/S (ADR) (NYSE:NVO ...
On June 25, 2014, Novo Nordisk A/S (ADR) (NYSE:NVO), is teaming up with NBA great and Hall of Famer Dominique Wilkins to launch Dominique's Diabetes Dream Team, a national initiative to help adults with type 2 diabetes customize a full-court approach ...
Related articles »  
Drug Manufacturers: Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Prana ...
On 1 JULY Novo Nordisk A/S (ADR) (NYSE:NVO) initiated a share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.
Related articles »  
Notable Stocks: MEI Pharma Inc (NASDAQ:MEIP), Dr. Reddy's Laboratories ...
On June 23, Novo Nordisk A/S (ADR) (NYSE:NVO) Victoza (liraglutide 3 mg) showed statistically significant results in the randomized, placebo-controlled, double-blind, phase IIIa SCALE Diabetes study (n=846) for chronic weight management.
Related articles »  
Trader's recap: Teva Pharmaceutical Industries (NYSE:TEVA), Amarin ...
On last trading day Novo Nordisk A/S (ADR) (NYSE:NVO) ended up 0.22% higher to close at $45.53 while trading in the range of $45.13 - $45.58.
Related articles »  
Novo Nordisk A/S Receives Neutral Rating from Zacks (NVO)
Zacks' analyst wrote, �Novo Nordisk reported first-quarter 2014 earnings of $0.45 per ADR, a penny above the Zacks Consensus Estimate of $0.44.
MannKind Corporation (NASDAQ:MNKD) Surged 9.60%: Furiex ...
On June 25, Novo Nordisk A/S (ADR) (NYSE:NVO) is teaming up with NBA great and Hall of Famer Dominique Wilkins to launch Dominique's Diabetes Dream Team, a national initiative to help adults with type 2 diabetes customize a full-court approach to ...
Novo Nordisk A/S: Share repurchase programme
Headquartered in Denmark, Novo Nordisk employs approximately. 40,000 employees in 75 countries, and markets its products in more than 180 countries.
Stocks to Track: Auxilium Pharmaceuticals, Inc. (AUXL), Tenet Healthcare Corp ...
Novo Nordisk A/S (ADR)(NYSE:NVO) engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark.
MannKind Surging On AFREZZA Approval
The company has spent over seven years and around $2 billion in the development of the drug, which will now be made available commercially.
Related articles »